AI Stock Analysis: Is HIMS a Buy?

May 20, 7:14 am

Hims & Hers Health, Inc. (ticker: HIMS) is a telehealth company that offers a range of wellness products and services. The company aims to revolutionize the healthcare sector by providing convenient and affordable access to treatments for conditions like hair loss, sexual health, and mental wellness. Customers can access these services online, making healthcare more accessible and less stigmatized.

Fundamental Analysis

In examining the financials, Hims has displayed notable growth over recent quarters. The revenue for the last quarter was $278 million, an impressive increase of 12.79% compared to the previous quarter. More significantly, there is a 45.81% increase compared to the same quarter last year. This consistent revenue growth indicates that Hims is successfully expanding its customer base and market share.

Net income for the last quarter stood at $11 million, which represents an astounding growth of 793.82% compared to the previous quarter. Year-over-year, net income has grown by 210.54%. This boost in profitability can be a sign that Hims is effectively managing its operational costs while scaling its services.

EBITDA for the last quarter also rose to $11 million, showing an astronomical increase of 3,434.33% compared to the quarter before. Year-over-year, EBITDA is up by 203.31%, another indication that the company is improving its operational efficiencies and creating value.

However, it's essential to note that there have been a couple of company insiders selling their stock recently. This could potentially be a bearish signal, as insider sales often indicate concerns about the company's future prospects.

Technical Analysis

Today's stock price of Hims is $19.09. This is a substantial increase of 60.42% compared to a month ago, indicating a strongly positive short-term trend. Taking a longer-term view, the stock price is up by 95.39% compared to a year ago, suggesting a sustained upward trend.

The current Simple Moving Average (SMA10) is 14.19, higher than the previous SMA10 of 13.51. This indicates a potential upward trend in price movement, reinforcing the bullish sentiment. The Relative Strength Index (RSI) stands at 26.1, indicating a potentially oversold condition, which often precedes a bullish period.

Alternative Data Analysis

Looking at alternative data points, Hims has 90 open positions according to data from the most popular job boards. This figure is up by 8% in the last couple of months, suggesting the company is looking to expand—often a healthy sign for future growth.

However, the number of visitors to Hims’ webpage is estimated at 1,000,000, down by 17% over the last couple of months. This decline in web traffic could be a worrisome trend, possibly indicating a loss in customer interest or engagement.

On a positive note, Hims’ social media engagement appears to be improving. They have 190,000 followers on their Instagram page, up by 8% in the last couple of months, and 9,200 followers on their Twitter page, up by 20%. This suggests increased interest in the company and its offerings.

Lastly, Hims has an AltIndex AI score of 69, which stands as a buy signal. This AI score is derived from fundamental, technical, and alternative data analyses, lending weight to the recommendation.

Conclusion and Recommendation

Taking into account all the factors, Hims appears to be a robust company demonstrating impressive financial growth and a positive trend both in the short and long term. The significant revenue and net income growth, combined with improved operational efficiencies as noted in the EBITDA figures, are promising signs. The technical indicators also support a bullish outlook, though the decrease in web traffic is a caveat to consider.

Given the data points from fundamental, technical, and alternative analyses along with the AltIndex AI score of 69, a buy recommendation seems warranted. However, potential investors should keep an eye on insider selling activities and declining web traffic, which may signal challenges ahead.

Disclaimer: This article, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current. Visit HIMS AI Stock Analysis for a more up-to-date analysis.

Get More Insights

Sign up and get access to a personalized dashboard, deeper insights, AI stock picks, stock alerts, weekly newsletter and much more.